Institutional investors purchased a net $1.3 million shares of NBY during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 12.98% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SOPHROSYNE CAPITAL LLC Bought 514.9 Thousand shares of NovaBay Pharmaceuticals I...